These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3097838)

  • 41. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?].
    Schlumpf U; Bussmann HU; Jerusalem F
    Schweiz Med Wochenschr; 1981 Jan; 111(1):29-35. PubMed ID: 6782670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do penicillamine and Myocrisin act the same way in rheumatoid arthritis?
    Munthe E; Jellum E; Aaseth J
    Rheumatol Rehabil; 1978; Suppl():105-8. PubMed ID: 103179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparisons of sulfasalazine to gold and placebo in the treatment of rheumatoid arthritis.
    Williams HJ
    J Rheumatol Suppl; 1988 Sep; 16():9-13. PubMed ID: 2903928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
    Seppälä E; Lehtinen K; Isomäki H; Nissilä M; Harmoinen A; Mörsky P; Koivula T; Vapaatalo H
    Int J Clin Pharmacol Res; 1988; 8(3):149-56. PubMed ID: 3136089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease-modifying agents in rheumatoid arthritis.
    Lipsky PE
    Ryumachi; 1987 Dec; 27(6):409-12. PubMed ID: 2455354
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical studies with salazopyrine--consequences and perspectives].
    Zeidler H
    Z Rheumatol; 1987; 46(2):59-66. PubMed ID: 2885985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial.
    Kvien TK; Høyeraal HM; Sandstad B
    J Rheumatol; 1985 Jun; 12(3):533-9. PubMed ID: 3930720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [HLA antigens and side effects of gold and D-penicillamine in chronic polyarthritis].
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb N
    Wien Klin Wochenschr Suppl; 1984; 156():51-2. PubMed ID: 6442059
    [No Abstract]   [Full Text] [Related]  

  • 50. [Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents].
    Menninger H; Burkhardt H
    Fortschr Med; 1983 Apr; 101(14):639-45. PubMed ID: 6406333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Gold therapy of rheumatic diseases].
    Berndt H
    Z Arztl Fortbild (Jena); 1987; 81(9):416. PubMed ID: 3114970
    [No Abstract]   [Full Text] [Related]  

  • 53. [Possible mechanism of action of drugs in the basic therapy of rheumatoid arthritis: effect on platelet aggregation].
    Fioravanti A; Lolatte V; Giordano N; Frati E; Castagna ML; Morozzi G; Lalumera M; Marcolongo R
    Boll Soc Ital Biol Sper; 1984 May; 60(5):1051-6. PubMed ID: 6432005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Precipitating autoantibody to a ubiquitous tissue antigen: association with rheumatoid arthritis treated with sodium aurothiomalate or d-penicillamine.
    Palosuo T; Kajander A; von Essen R; Milgrom F
    Clin Immunol Immunopathol; 1978 Jul; 10(3):355-64. PubMed ID: 97039
    [No Abstract]   [Full Text] [Related]  

  • 55. Is gold necessary in so called chrysotherapy?
    Munthe E; Jellum E
    Scand J Rheumatol Suppl; 1983; 51():46-51. PubMed ID: 6426053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rheumatoid arthritis: limiting the damage.
    Hosie G
    Nurs Times; 2002 Mar 28-Apr 1; 98(13):34-6. PubMed ID: 11974758
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-term (four year) clinical trial with tenoxicam and basis therapy in patients suffering from rheumatoid arthritis.
    Lalos J; Tsachalos P; Gallis L
    Scand J Rheumatol Suppl; 1989; 80():67-70. PubMed ID: 2512637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Results with D-penicillamine in the treatment of rheumatoid arthritis].
    Otto W; Pietruschka WD; Beenken O
    Reumatizam; 1975; 22(3):90-3. PubMed ID: 1096256
    [No Abstract]   [Full Text] [Related]  

  • 59. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
    Grindulis KA; McConkey B
    Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
    Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S
    J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.